A Combination of DR5 Agonistic Monoclonal Antibody with Gemcitabine Targets Pancreatic Cancer Stem Cells and Results in Long-term Disease Control in Human Pancreatic Cancer ModelN.V. Rajeshkumar, Manuel Hidalgo|Molecular Cancer Therapeutics|2010Cited by 88
Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancerN.V. Rajeshkumar, Manuel Hidalgo|British Journal of Cancer|2016Cited by 51